Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OsteoNovus is a private orthopedic medical device company focused on synthetic biomaterials that support and regenerate bone. Its core technology is the NovoGro platform, a synthetic calcium phosphate-based bone graft and bone substitute technology designed for applications including bone voids, fractures, and spinal procedures. The company markets products such as NovoGro Putty and emphasizes biomimetic bone remodeling and regeneration. OsteoNovus appears to operate as an early-stage but active commercial medtech company rather than a traditional therapeutics developer. Its operations are based in Toledo, Ohio, with additional Asia-Pacific business development presence through OsteoNovus K.K.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OsteoNovus.